What is behind programmatic treatment outcome definitions for tuberculosis?
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
484 0
SM ISO690:2012
AVALIANI, Zaza, GOZALOV, Ogtay, KUCHUKHIDZE, Giorgi, SKRAHINA, Alena, SOLTAN, Viorel, VAN DEN BOOM, Martin, VASILYEVA, Irina, VÎLC, Valentina, YEDILBAYEV, Askar B.. What is behind programmatic treatment outcome definitions for tuberculosis? In: European Respiratory Journal, 2020, vol. 56, p. 0. ISSN 0903-1936. DOI: https://doi.org/10.1183/13993003.01751-2020
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
European Respiratory Journal
Volumul 56 / 2020 / ISSN 0903-1936 /ISSNe 1399-3003

What is behind programmatic treatment outcome definitions for tuberculosis?

DOI:https://doi.org/10.1183/13993003.01751-2020

Pag. 0-0

Avaliani Zaza1, Gozalov Ogtay2, Kuchukhidze Giorgi2, Skrahina Alena3, Soltan Viorel4, van den Boom Martin2, Vasilyeva Irina5, Vîlc Valentina6, Yedilbayev Askar B.2
 
1 National Center for Tuberculosis and Lung Diseases, Tbilisi,
2 WHO Regional Office for Europe,
3 Republican Scientific and Practical Centre of Pulmonology and Tuberculosis, Ministry of Health, Minsk,
4 Stop TB Partnership, Geneva,
5 National Medical Research Center of Phthisiopulmonology and Infectious Diseases, Moscow,
6 Institute of Phtysiopneumology „Chiril Draganiuc”
 
 
Disponibil în IBN: 8 octombrie 2020


Cuvinte-cheie
clinical decision making, death, disease surveillance, health care planning, health care policy, health program, health service, human, Infection control, Medical technology, Multidrug Resistant Tuberculosis, priority journal, review, sputum smear, treatment outcome, tuberculosis